Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 14NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Leukemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

Methotrexate 2Cyclosporine 2merphos 1hydrocortisone hemisuccinate 1Whole-Body Irradiation 1Thioguanine 1Radiotherapy 1Photopheresis 1Peripheral Blood Stem Cell Transplantation 1Pentostatin 1Mycophenolic Acid 1Methoxsalen 1Hydrocortisone 1Daunorubicin 1Cytarabine 1Cyclosporins 1Asparaginase 1Antilymphocyte Serum 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Anemia, Refractory × Antilymphocyte Serum × Clear all
NCT00016419 2015-03-06

S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome

SWOG Cancer Research Network

Phase 2 Completed
130 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡